Kidney Cancer

Obesity Paradox in Renal Cell Carcinoma: Why Do Patients Who Are Obese Have Improved Survival?

By

Jessica Nye, PhD

Publish Date May 11, 2021

A review of retrospective data sought to better understand the relationship between obesity and survival in renal cell carcinoma.

Local Salvage Therapy Effective for Local, Regional Recurrence of RCC

By

Jody A. Charnow

Publish Date April 26, 2021

Local surgery or ablation may be most appropriate for patients with a solitary site of locoregional recurrence following definitive surgery for clinically localized renal cell carcinoma, according to investigators.

Interplay Between Histologic Subtype of Renal Cell Carcinoma and Metastasis Site Affect Overall Survival

By

Jessica Nye, PhD

Publish Date April 23, 2021

Researchers determined the most common sites of metastasis and their association with overall survival rate for the 3 main subtypes of RCC.

Factors Associated With Response to Nivolumab in Renal Cell Carcinoma

By

Andrea S. Blevins Primeau, PhD, MBA

Publish Date April 9, 2021

A study was conducted to assess factors contributing to response to nivolumab treatment for advanced clear cell renal cell carcinoma.

Belzutifan Gets Priority Review for Von Hippel-Lindau Disease-Associated RCC

By

Diana Ernst, RPh

Publish Date March 17, 2021

Belzutifan is a potent and selective inhibitor of HIF-2α.